Tandem Diabetes Care (TNDM) shares fell Monday after analysts from Wells Fargo and Bernstein downgraded the stock.
Tandem shares were more down more than 4% in recent trading after falling as much as 5.8% earlier.
Wells Fargo downgraded the stock to equal weight from overweight and cut its price target to $22 from $38, and Bernstein to market perform from outperform.
Trading volume stood at over 1.8 million shares against a daily average of about 1.3 million.
Price: 21.12, Change: -1.02, Percent Change: -4.61
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。